 Over 1,500 people registered for the event, with the majority reporting increased understanding of mechanistic models and improved consensus on model validation and verification. Additionally, the workshop helped clarify regulatory expectations for mechanistic models submitted in abbreviated new drug applications. This article was authored by Andrew Babiskin, Fong Wu, Yusef Musa, and others.